uniQure N.V. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
32,809.00
64,397.70
221,096.80
132,496.00
159,371.00
234,898
Total Accounts Receivable
3,570.30
4,178.30
5,310.90
9,180.00
1,586.00
233
Inventories
1,191.90
242.00
472.50
-
-
-
Other Current Assets
538.80
623.20
687.60
2,270.00
1,826.00
1,445
Total Current Assets
38,110.00
69,441.10
227,567.90
143,946.00
162,783.00
236,576
Net Property, Plant & Equipment
3,602.00
23,798.10
25,875.70
35,702.00
34,281.00
29,179
Total Investments and Advances
-
1,236.70
1,240.60
1,828.00
2,480.00
2,444
Intangible Assets
10,713.60
21,430.00
8,311.30
8,789.00
10,100.00
5,707
Other Assets
1,271.90
-
-
-
-
-
Total Assets
53,697.30
115,905.80
262,995.40
190,265.00
209,644.00
273,906
ST Debt & Current Portion LT Debt
2,166.10
1,031.00
6,902.40
605.00
1,050.00
Accounts Payable
4,832.50
5,880.80
4,166.00
5,524.00
2,908.00
Other Current Liabilities
7,403.70
7,937.90
15,413.50
16,592.00
15,272.00
Total Current Liabilities
14,402.30
14,849.70
26,481.80
22,721.00
19,230.00
Long-Term Debt
9,086.20
20,028.70
15,169.10
19,631.00
19,741.00
Deferred Taxes
-
1,668.70
-
-
-
Other Liabilities
22,541.90
27,224.90
91,549.00
84,282.00
81,314.00
Total Liabilities
46,030.40
63,772.10
133,199.90
126,634.00
120,285.00
Common Equity (Total)
7,666.90
52,133.80
129,795.50
63,631.00
89,359.00
Total Shareholders' Equity
7,666.90
52,133.80
129,795.50
63,631.00
89,359.00
Total Equity
7,666.90
52,133.80
129,795.50
63,631.00
89,359.00
Liabilities & Shareholders' Equity
53,697.30
115,905.80
262,995.40
190,265.00
209,644.00

About uniQure

View Profile
Address
Paasheuvelweg 25a
Amsterdam Noord-Holland 1105 BP
Netherlands
Employees -
Website http://www.uniqure.com
Updated 07/08/2019
uniQure NV engages in the research, development, and commercialization of gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded on January 9, 2012 and is headquartered in Amsterdam, the Netherlands.